Market Cap 44.91B
Revenue (ttm) 6.95B
Net Income (ttm) 1.30B
EPS (ttm) N/A
PE Ratio 26.90
Forward PE 25.92
Profit Margin 18.75%
Debt to Equity Ratio 0.43
Volume 2,425,298
Avg Vol 2,137,952
Day's Range N/A - N/A
Shares Out 282.43M
Stochastic %K 49%
Beta 1.25
Analysts Strong Sell
Price Target $160.00

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufact...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 800 227 9770
Address:
5301 Stevens Creek Boulevard, Santa Clara, United States
AnalystKrishna
AnalystKrishna Aug. 25 at 6:13 AM
$A 5+ years of consolidation and trading between 95/100 - 153/160. Can invest few for short term target of 179.4 If on good earnings and if this crosses 180 then all is good for its investors and they can see the price rising to 252 in next 6 to 8 months. On not-so-expected earnings, this can again fallback to 134, 120, 110 and will rise again to 160. Short term ROI --> 17% Long term ROI --> 64.5%
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 21 at 6:31 PM
$A printed a new 52-week high today
0 · Reply
KingAJ6
KingAJ6 Aug. 21 at 4:12 PM
$SPPI $SPY $AAPL $A $MSFT 480P 8/21 @0.14
0 · Reply
stockanalysis_
stockanalysis_ Aug. 20 at 9:59 PM
After Hours Losers 1. $JZ -29.22% 2. $FLUX.X -19.62% 3. $YOUL -13.89% 4. $OSIS -13.79% 5. $A -13.32%
0 · Reply
CarolDonaldson311
CarolDonaldson311 Aug. 5 at 6:46 AM
$SYY $NTRA $A $ESLT $HMC Sysco leads food distribution, Natera dominates genetic testing, Agilent Technologies benefits from life science demand, Elbit Systems gains from defense spending, and Honda continues advancing hybrid and EV technologies.
0 · Reply
KateBlack770
KateBlack770 Aug. 3 at 2:45 PM
$WDAY $ED $IBKR $TEVA $A Workday leads enterprise software, Consolidated Edison provides stable utility income, Interactive Brokers benefits from trading activity, Teva continues restructuring, and Agilent Technologies leads life science instrumentation.
0 · Reply
Estimize
Estimize Aug. 3 at 2:12 PM
Wall St is expecting 1.49 EPS for $A Q3 [Reporting 08/26 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 28 at 4:23 PM
$SLS Look at this SHORT IDIOT TOOL - Stuck its MEAT into the GRINDER... Dr. Tsirigotis KNOWS --- He absolutely Knows -- treats more REGAL P3 Patients than any other clinician and Stated on the Record - "MOS for patients on BAT is extremely poor, just 5 -7 months" and " I STRONGLY Believe Gps will Reach the Primary Endpoint..." So Many Idiot short tools / retail traders too, getting FLEECED... $ABBV $A
1 · Reply
LewisDaKat
LewisDaKat Jul. 23 at 2:00 PM
$A Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma https://marketwirenews.com/stock/a/news/agilent-receives-eu-approval-for-pd-l1-ihc-22c3-phar-5150562317732921.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Jul. 21 at 3:00 PM
$A Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure https://marketwirenews.com/stock/a/news/gilead-to-present-new-hiv-research-at-aids-2026-acro-5182713870505921.html?utm_source=stocktwits
0 · Reply
Latest News on A
Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx

2026-07-23T12:16:03.000Z - 4 weeks ago

Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx


Agilent Increases Its Investment in HALO X-ray Technologies

Jul 20, 2026, 3:11 AM EDT - 5 weeks ago

Agilent Increases Its Investment in HALO X-ray Technologies


Agilent price target raised to $135 from $130 at Jefferies

2026-07-09T12:46:18.000Z - 6 weeks ago

Agilent price target raised to $135 from $130 at Jefferies


Agilent introduces Altura SEC, Altura PLRP-S columns

2026-07-08T12:10:42.000Z - 6 weeks ago

Agilent introduces Altura SEC, Altura PLRP-S columns


Agilent price target raised to $148 from $144 at Evercore ISI

2026-07-06T12:40:44.000Z - 7 weeks ago

Agilent price target raised to $148 from $144 at Evercore ISI


Agilent launches Agilent xCELLigence RTCA eSight AI

2026-07-01T12:10:49.000Z - 7 weeks ago

Agilent launches Agilent xCELLigence RTCA eSight AI


Agilent resumed with an Outperform at Bernstein

2026-06-26T10:25:14.000Z - 2 months ago

Agilent resumed with an Outperform at Bernstein


Agilent completes acquisition of Biocare Medical

2026-06-25T12:10:51.000Z - 2 months ago

Agilent completes acquisition of Biocare Medical


Agilent Completes Acquisition of Biocare Medical

Jun 25, 2026, 8:00 AM EDT - 2 months ago

Agilent Completes Acquisition of Biocare Medical


Agilent initiated with a Neutral at Piper Sandler

2026-06-11T09:50:53.000Z - 2 months ago

Agilent initiated with a Neutral at Piper Sandler


Agilent announces collaboration with OpenAI, BCG

2026-06-03T11:24:55.000Z - 2 months ago

Agilent announces collaboration with OpenAI, BCG


Agilent price target lowered to $165 from $180 at HSBC

2026-06-03T09:32:42.000Z - 2 months ago

Agilent price target lowered to $165 from $180 at HSBC


Agilent price target raised to $155 from $145 at BofA

2026-06-02T11:38:30.000Z - 3 months ago

Agilent price target raised to $155 from $145 at BofA


Agilent assumed with a Peer Perform at Wolfe Research

2026-06-01T21:11:49.000Z - 3 months ago

Agilent assumed with a Peer Perform at Wolfe Research


Agilent initiated with a Peer Perform at Wolfe Research

2026-06-01T20:54:03.000Z - 3 months ago

Agilent initiated with a Peer Perform at Wolfe Research


Agilent Technologies Earnings Call Transcript: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Earnings Call Transcript: Q2 2026


Agilent Technologies Slides: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Slides: Q2 2026


Agilent Technologies Earnings release: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Earnings release: Q2 2026


Agilent Technologies Quarterly report: Q2 2026

May 27, 2026, 4:30 PM EDT - 3 months ago

Agilent Technologies Quarterly report: Q2 2026


Agilent Announces Cash Dividend of 25.5 Cents per Share

May 20, 2026, 4:27 PM EDT - 3 months ago

Agilent Announces Cash Dividend of 25.5 Cents per Share


Agilent to Participate in Jefferies Global Healthcare Conference

May 11, 2026, 4:15 PM EDT - 3 months ago

Agilent to Participate in Jefferies Global Healthcare Conference


Agilent Names Michael Buckner as Chief Legal Officer

May 4, 2026, 8:00 AM EDT - 4 months ago

Agilent Names Michael Buckner as Chief Legal Officer


Axion BioSystems and Agilent Technologies Resolve Litigation

Apr 21, 2026, 8:00 AM EDT - 4 months ago

Axion BioSystems and Agilent Technologies Resolve Litigation


Agilent Showcases Cancer Research Solutions at AACR 2026

Apr 15, 2026, 8:00 AM EDT - 4 months ago

Agilent Showcases Cancer Research Solutions at AACR 2026


Agilent Technologies Slides: Corporate presentation

Mar 27, 2026, 7:00 AM EDT - 5 months ago

Agilent Technologies Slides: Corporate presentation


Agilent Technologies Earnings Call Transcript: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings Call Transcript: Q1 2026


Agilent Technologies Quarterly report: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Quarterly report: Q1 2026


Agilent Technologies Earnings release: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Earnings release: Q1 2026


Agilent Technologies Slides: Q1 2026

Feb 25, 2026, 4:30 PM EST - 6 months ago

Agilent Technologies Slides: Q1 2026


Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

Feb 25, 2026, 4:05 PM EST - 6 months ago

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results


Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing


Agilent Technologies Proxy statement: Proxy Filing

Feb 6, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing


Agilent Technologies Proxy statement: Proxy Filing

Jan 23, 2026, 7:00 AM EST - 7 months ago

Agilent Technologies Proxy statement: Proxy Filing


Top small-cap plays for 2026

Nov 25, 2025, 1:24 PM EST - 9 months ago

Top small-cap plays for 2026

COHR DG EW TXT VLO


Agilent Technologies Earnings Call Transcript: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Earnings Call Transcript: Q4 2025


Agilent Technologies Annual report: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Annual report: Q4 2025


Agilent Technologies Earnings release: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Earnings release: Q4 2025


Agilent Technologies Slides: Q4 2025

Nov 24, 2025, 4:30 PM EST - 9 months ago

Agilent Technologies Slides: Q4 2025


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 9 months ago

Josh Brown's ‘best stocks in the market': Health Care

LLY MTD TMO XLV


Agilent Announces Cash Dividend of 25.5 Cents Per Share

Nov 19, 2025, 4:15 PM EST - 9 months ago

Agilent Announces Cash Dividend of 25.5 Cents Per Share


AnalystKrishna
AnalystKrishna Aug. 25 at 6:13 AM
$A 5+ years of consolidation and trading between 95/100 - 153/160. Can invest few for short term target of 179.4 If on good earnings and if this crosses 180 then all is good for its investors and they can see the price rising to 252 in next 6 to 8 months. On not-so-expected earnings, this can again fallback to 134, 120, 110 and will rise again to 160. Short term ROI --> 17% Long term ROI --> 64.5%
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Aug. 21 at 6:31 PM
$A printed a new 52-week high today
0 · Reply
KingAJ6
KingAJ6 Aug. 21 at 4:12 PM
$SPPI $SPY $AAPL $A $MSFT 480P 8/21 @0.14
0 · Reply
stockanalysis_
stockanalysis_ Aug. 20 at 9:59 PM
After Hours Losers 1. $JZ -29.22% 2. $FLUX.X -19.62% 3. $YOUL -13.89% 4. $OSIS -13.79% 5. $A -13.32%
0 · Reply
CarolDonaldson311
CarolDonaldson311 Aug. 5 at 6:46 AM
$SYY $NTRA $A $ESLT $HMC Sysco leads food distribution, Natera dominates genetic testing, Agilent Technologies benefits from life science demand, Elbit Systems gains from defense spending, and Honda continues advancing hybrid and EV technologies.
0 · Reply
KateBlack770
KateBlack770 Aug. 3 at 2:45 PM
$WDAY $ED $IBKR $TEVA $A Workday leads enterprise software, Consolidated Edison provides stable utility income, Interactive Brokers benefits from trading activity, Teva continues restructuring, and Agilent Technologies leads life science instrumentation.
0 · Reply
Estimize
Estimize Aug. 3 at 2:12 PM
Wall St is expecting 1.49 EPS for $A Q3 [Reporting 08/26 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 Jul. 28 at 4:23 PM
$SLS Look at this SHORT IDIOT TOOL - Stuck its MEAT into the GRINDER... Dr. Tsirigotis KNOWS --- He absolutely Knows -- treats more REGAL P3 Patients than any other clinician and Stated on the Record - "MOS for patients on BAT is extremely poor, just 5 -7 months" and " I STRONGLY Believe Gps will Reach the Primary Endpoint..." So Many Idiot short tools / retail traders too, getting FLEECED... $ABBV $A
1 · Reply
LewisDaKat
LewisDaKat Jul. 23 at 2:00 PM
$A Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma https://marketwirenews.com/stock/a/news/agilent-receives-eu-approval-for-pd-l1-ihc-22c3-phar-5150562317732921.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Jul. 21 at 3:00 PM
$A Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure https://marketwirenews.com/stock/a/news/gilead-to-present-new-hiv-research-at-aids-2026-acro-5182713870505921.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Jul. 14 at 10:00 PM
$A Lira Clinical Announces New REGEN Line - A First-of-Its-Kind Breakthrough in Regenerative Skincare https://marketwirenews.com/stock/a/news/lira-clinical-announces-new-regen-line-a-first-of-it-6694639445227332.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Jul. 14 at 7:00 PM
$A Quebec's Real Estate Market Gradually Rebalances in the Second Quarter https://marketwirenews.com/stock/a/news/quebec-s-real-estate-market-gradually-rebalances-in--6866626285772635.html?utm_source=stocktwits
0 · Reply
LewisDaKat
LewisDaKat Jul. 14 at 6:30 PM
$A Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma https://marketwirenews.com/stock/a/news/agilent-receives-fda-approval-for-pd-l1-ihc-28-8-pha-8339272714637069.html?utm_source=stocktwits
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jul. 10 at 2:22 PM
$A Jefferies has altered their rating of "Hold" and target of "$135" see consensus outlook
0 · Reply
BreakoutsHappen
BreakoutsHappen Jul. 7 at 5:51 AM
Reversal Bullish Today: $MMM $A $DOV $INTU
0 · Reply
KeepItRealistic
KeepItRealistic Jul. 5 at 2:20 PM
$GDC As of today (July 2026), there are exactly two public companies with Bitcoin treasuries reported at precisely 7,500 BTC:  • American Bitcoin Corp $A B TC — ~7,500 BTC (ranks around #16 on major trackers). • GD Culture Group ($GDC) — 7,500 BTC (ranks right behind or alongside ABTC). Key Context from Trackers Major sources like http://BitcoinTreasuries.net, CoinGecko, and others consistently list only these two at that exact round number. No other public companies (or prominent private/government entities) are currently reported with precisely 7,500 BTC.  Look at the difference in Market Caps 👇 🤷🏻‍♂️
4 · Reply
sullivan1
sullivan1 Jul. 4 at 3:26 AM
$ADTX $A/ S 10B https://www.sec.gov/Archives/edgar/data/1641398/000121390025089638/ea0258126-pre14c_gdculture.htm
0 · Reply
SuperGreenToday
SuperGreenToday Jul. 2 at 9:45 AM
$A Share Price: $133.35 Contract Selected: Nov 20, 2026 $135 Calls Buy Zone: $10.58 – $13.07 Target Zone: $17.56 – $21.46 Potential Upside: 57% ROI Time to Expiration: 140 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jun. 30 at 2:28 AM
$A Bernstein has altered their rating of "Outperform" and target of "$155" see consensus outlook
0 · Reply
BEST_MAN_EVER
BEST_MAN_EVER Jun. 28 at 1:13 PM
$SKM 🇰🇷 SK Telecom owns ~0.3% of Anthropic, bought early. L Here's what that 0.3% slice would be worth at different Anthropic valuations, and how big it looms next to SKT's own ~$14B market cap: $1.0T → $3.0B (~21% of SKT) $1.5T → $4.5B (~32%) $2.0T → $6.0B (~43%) $2.5T → $7.5B (~54%) So at a $2.5T Anthropic, the stake alone ≈ half of SKT's entire value. A pre-IPO backdoor into Anthropic. $A £maaft7h;
0 · Reply
Dr_Stoxx
Dr_Stoxx Jun. 25 at 7:48 PM
$A in the strong medtech space. Note the OBV indicator, how strong it is here with price still pretty muted. (just added this to the mix).
0 · Reply